Research News – Spring 2020
MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. FDA Agrees to Expanded Access Program for MDMA-Assisted Therapy for PTSD On December 20, 2019, the U.S. Food and Drug Administration (FDA) …
Bulletin Category: Bulletin: Spring 2020
The Commercial Chemistry of MDMA: From Research to Patient Access
Written by Heather Clouting, M.Sc. MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. Nearly 20 years ago, during our final year of university while studying for our Bachelor’s in chemistry, …
The FDA and Psychedelic Drug Development: Working Together to Make Medicines
Written by Victoria Hale, Ph.D. MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. The Multidisciplinary Association for Psychedelic Studies (MAPS), the Usona Institute, and Compass Pathways …
Psychedelic Medicalization: How Do We Get It Right?
Written by Greg Kearns MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. As clinical trials for the use of medicines like MDMA and psilocybin in psychedelic-assisted psychotherapy (PAT) …
The Pollination Approach to Delivering Psychedelic-Assisted Mental Healthcare
Written by Bennet A. Zelner MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. In this article I outline a novel economic approach for delivering psychedelic-assisted mental healthcare, the …
A North Star for the Emerging Psychedelics Industry
Written by Liana Sananda Gillooly and Kat Conour MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. The field of psychedelics is rapidly expanding, with a Cambrian explosion of new entities …
Expanding Ancestral Knowledge Beyond the Sale of Molecules: Iboga and Ibogaine in the Context of Psychedelic Commercialization
Written by Ricard Faura, Ph.D, Andrea Langlois, and José Carlos Bouso, Ph.D. MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. From Gabon to all corners of the globe, practices with iboga …
The Commercialization of Ibogaine to Treat Substance Use Disorders and Other Psychiatric Conditions in the United States: A Doctor’s View
MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article.
The Growth of Psychedelic Harm Reduction
Written by Adam Rubin MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. I have just returned from coordinating and providing psychedelic peer support and harm reduction services at a music …
Psychedelic Legalization: An Opportunity to Change Our Perspective on Equity
Written by Amber E. Senter MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. Since psychedelics were discovered, human beings have used them to detach from harmful mental patterns, reassess …
The Emergence of a New Market: Psychedelic Science Conferences
Written by Bia Labate, Ph.D. MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download this article. I confess I am a conference nerd. I love conferences: I like to attend them, to speak at them, and most of …
Sacred Peyote Conservation: Respecting Indigenous Traditions
https://mapscontent.s3-us-west-1.amazonaws.com/images/MAPS-Bulletin-2020-Spring-Peyote.png Written by Sandor Iron Rope, Refina Smith, and Steven Moore MAPS Bulletin Spring 2020: Vol. 30, No. 1 Download …